secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACURA PHARMACEUTICALS, INC (—)
CIK:        0000786947
Form:       8-K
Filed at:   2023-09-01T23:59:59+00:00
Accession:  0001104659-23-097455
Event type: debt
Sentiment:  negative
Materiality: 0.85
Item codes: 1.01, 2.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acura receives $250k loan from majority owner, total debt $4.17M; warns operations may cease without further financing
--------------------------------------------------------------------------------

- New $250k loan from Abuse Deterrent Pharma (66% owner) on Aug 30, 2023; total principal under note now $4,169,279.
- Loan bears 5.25% interest, matures Dec 31, 2023; default rate 7.5%.
- Proceeds only fund operations through mid-October 2023; company warns may scale back or cease operations without additional financing.
- AD Pharma directly owns ~66% of common stock; its managing partner Mr. Schutte owns ~14% personally.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/786947/000110465923097455/0001104659-23-097455-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/786947/000110465923097455/tm2325185d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-097455

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer